Welcome to our dedicated page for Equifax SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Equifax Inc. (NYSE: EFX) is a global data, analytics, and technology company whose SEC filings provide detailed insight into its credit reporting, workforce solutions, and compliance businesses. Through its periodic reports and current reports, Equifax discloses information about its financial condition, results of operations, risk factors, and significant corporate events.
On this page, you can review Equifax’s U.S. Securities and Exchange Commission filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its data, analytics, and cloud technology strategy, global operations across 24 countries, and the performance of areas such as consumer credit information and workforce solutions. Current reports on Form 8-K, such as those filed to announce quarterly financial results, provide timely updates on material events affecting the company.
Investors and analysts can also use this page to access other key documents, including proxy materials related to governance and executive compensation and, where applicable, insider transaction reports on Form 4 that show purchases and sales of Equifax securities by directors and officers. These filings help explain how Equifax manages its role as one of the major U.S. credit bureaus and as a provider of employment verification, AML compliance, and cloud-based analytics solutions.
Stock Titan enhances these filings with AI-powered summaries that highlight important sections and clarify complex disclosures. Real-time updates from the SEC’s EDGAR system ensure that new Equifax filings, including 10-Ks, 10-Qs, 8-Ks, and Forms 3 and 4, are available quickly, while AI-generated insights help readers understand the implications of changes in strategy, risk disclosures, and capital allocation for EFX shareholders.
Form 144 filed for EFX reporting a proposed sale of up to 4,500 common shares through Fidelity Brokerage Services LLC on 02/23/2026 for trading on the NYSE.
The filing lists several restricted stock vesting entries for common shares dated 02/16/2020 (642 shares), 02/21/2023 (3,650 shares) and 02/12/2024 (208 shares); these vesting items are described in the excerpt as compensation-related vesting events.
Equifax Inc. describes itself as a global data, analytics and technology company serving financial institutions, governments, employers and consumers. It operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS) and International, providing credit data, verification, decisioning tools and fraud management.
The company highlights a multi‑year shift to the Equifax Cloud, using a single data fabric, artificial intelligence and machine learning to speed product development, improve uptime and support advanced analytics. Its Workforce Solutions unit is anchored by The Work Number platform, which held about 209 million active and 813 million total employment records at December 31, 2025.
International operations in Latin America, Europe, Asia Pacific and Canada generated 23% of 2025 revenue, with broad use of government and commercial data sources. Equifax employed about 15,000 people in 22 countries, hiring roughly 2,700 and promoting 1,800 employees in 2025.
Key risks center on cybersecurity, loss of critical data sources, evolving global privacy and AI regulation, competition from other bureaus and free data alternatives, execution of its cloud transformation, economic sensitivity (notably to U.S. mortgage volumes) and dependence on key certifications and government contracts.
Equifax executive vice president and Chief Product Officer Cecilia Mao bought 2,400 shares of EQUIFAX INC common stock in an open-market transaction at $193.72 per share. After this purchase, she directly owns 10,623 common shares, increasing her personal equity stake in the company.
Harris Associates L.P. and Harris Associates, Inc. report a 6.2% beneficial ownership stake in Equifax Inc. common stock as of December 31, 2025. They disclose beneficial ownership of 7,557,127 shares, with 7,014,715 shares subject to sole voting power and all 7,557,127 subject to sole dispositive power.
The firms state the shares are held in the ordinary course of business through advisory relationships, and that they were not acquired to change or influence control of Equifax. The filing is signed by Joseph J. Allessie as General Counsel and Secretary.
Equifax Inc. executive Chad M. Borton, EVP and President of Workforce Solutions, sold 2,535 shares of Equifax common stock in an open-market transaction at $191.50 per share. After this sale on 02/12/2026, he directly held 17,340 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on 11/4/2025, which allows insiders to systematically sell shares according to preset instructions.
Capital International Investors filed an amended Schedule 13G reporting beneficial ownership of 6,591,029 shares of Equifax common stock, representing 5.4% of the class. The filing is based on 122,394,037 shares believed outstanding as of the event date 12/31/2025.
The firm reports sole voting power over 6,530,805 shares and sole dispositive power over 6,591,029 shares, with no shared voting or dispositive power. It certifies the shares were acquired and are held in the ordinary course of business, not to change or influence control of Equifax.
Equifax Inc. executive Kathryn Q. Walker reported a small share disposition related to taxes. On 02/10/2026, she used 291 shares of Equifax common stock, at a price of $202.71 per share, to satisfy tax withholding obligations. After this tax-withholding disposition, she directly beneficially owned 1,776 shares of Equifax common stock, which include accrued dividend equivalent units tied to restricted stock units through the company’s last dividend payment date.
Equifax Inc. executive Harald Schneider, EVP and Chief D&A Officer, reported stock-based compensation and related tax withholding. On February 10, 2026, he acquired 1,374 shares of common stock at $0.0000 per share through a grant or award.
On the same date, 929 shares of common stock were disposed of at $202.71 per share to satisfy tax withholding obligations. After these transactions, Schneider directly beneficially owned 6,226 shares of Equifax common stock, including accrued dividend equivalent units tied to restricted stock units.
Equifax Inc. executive Cecilia Mao reported equity transactions in company stock. On 02/10/2026, she received a grant of 1,374 shares of Equifax common stock at $0.0000 per share, described as a grant, award, or other acquisition. On the same date, 918 shares were disposed of at $202.71 per share to satisfy tax withholding obligations, characterized as a tax-withholding disposition by delivering securities. After these transactions, she directly owned 8,223 shares of Equifax common stock, including accrued dividend equivalent units for reinvested dividends.
Equifax EVP and Chief Legal Officer Julia A. Houston reported insider stock transactions. On February 10, 2026, she acquired 4,119 shares of Equifax common stock in a grant at $0.0000 per share, then disposed of 2,614 shares at $202.71 per share to cover tax obligations. After these transactions, she directly owned 17,446 shares, including dividend equivalent units reinvested in related restricted stock units.